← Open Payments lookup

HARMEET KAUR: Open Payments

NPI 1417575671 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$357 in 21 payments from 8 companies in 2025. Trend: 2023 $421 · 2024 $648 · 2025 $357

Food & beverage: $357
CompanyPaymentsAmount
ABBVIE INC.11$171
Otsuka America Pharmaceutical, Inc.2$40
Janssen Pharmaceuticals, Inc2$35
Corium, LLC2$34
Teva Pharmaceuticals USA, Inc.1$25
Lundbeck LLC1$19
Almatica Pharma LLC1$17
Takeda Pharmaceuticals U.S.A., Inc.1$16

Products named: VRAYLAR, REXULTI, INVEGA, Azstarys, AUSTEDO XR, LOREEV XR, TRINTELLIX.

Industry payments across TX — which companies pay providers there.